Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives

Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives Publisher

Keshavarzfathi M^{1, 2, 3} ; Rezaei N^{3, 4, 5}

Show Affiliations

1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran
3. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives Published:2018

Abstract

Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of allogeneic and autologous cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines. © 2018 Elsevier Ltd. All rights reserved.

Style	Citing Format
MLA	Keshavarzfathi M, Rezaei N. "Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, vol. , no. , 2018, pp. 1-198.
APA	Keshavarzfathi M, Rezaei N (2018). Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), 1-198.
Chicago	Keshavarzfathi M, Rezaei N. "Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives , no. (2018): 1-198.
Harvard	Keshavarzfathi M, Rezaei N (2018) 'Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives', Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), pp. 1-198.
Vancouver	Keshavarzfathi M, Rezaei N. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives. 2018;():1-198.
BibTex	@article{ author = {Keshavarzfathi M and Rezaei N}, title = {Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives}, journal = {Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives}, volume = {}, number = {}, pages = {1-198}, year = {2018} }
RIS	TY - JOUR AU - Keshavarzfathi M AU - Rezaei N TI - Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives JO - Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives VL - IS - SP - 1 EP - 198 PY - 2018 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract